Lewis Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
3,649
+260
+8% +$89K 0.46% 57
2026
Q1
$1.19M Buy
3,389
+177
+6% +$63.1K 0.49% 52
2025
Q4
$1.05M Buy
3,212
+103
+3% +$32.7K 0.43% 58
2025
Q3
$877K Sell
3,109
-28
-0.9% -$8.12K 0.36% 67
2025
Q2
$876K Buy
3,137
+961
+44% +$272K 0.41% 63
2025
Q1
$678K Buy
2,176
+251
+13% +$74.1K 0.56% 47
2024
Q4
$502K Buy
1,925
+427
+29% +$127K 0.38% 62
2024
Q3
$483K Buy
1,498
+291
+24% +$95.2K 0.35% 70
2024
Q2
$377K Buy
1,207
+51
+4% +$15K 0.29% 76
2024
Q1
$329K Buy
1,156
+145
+14% +$42.4K 0.27% 84
2023
Q4
$291K Buy
+1,011
New +$275K 0.27% 86

Other funds holding AMGN

Lewis Asset Management's AMGN Position: Q2 2026 in Review

Lewis Asset Management increased its Amgen (AMGN) stake by 7.7% in Q2 2026, buying an estimated $89K and bringing the position to 3,649 shares worth $1.32M. The position accounts for 0.46% of the portfolio, ranked #57.

Lewis Asset Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,464 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Lewis Asset Management held 3,649 shares of Amgen worth $1.32M as of Q2 2026.
  • Lewis Asset Management bought 260 Amgen shares in Q2 2026, an estimated $89K.
  • Amgen made up 0.46% of Lewis Asset Management's portfolio in Q2 2026, its #57 holding.
  • Lewis Asset Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 1,464 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Lewis Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.